Neurocrine Biosciences shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 8.7k | 131.76 |
| 2022-12-31 | $418k | 3.5k | 119.44 |
| 2022-03-31 | $817k | 8.7k | 93.77 |
| 2020-09-30 | $442k | 4.6k | 96.09 |
| 2019-12-31 | $1.5M | 14k | 107.52 |
| 2018-09-30 | $382k | 3.1k | 122.87 |
| 2017-12-31 | $880k | 11k | 77.60 |
| 2017-09-30 | $274k | 4.5k | 61.35 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management